PALMOPLANTAR PUSTULOSIS (PPP)
Clinical trials for PALMOPLANTAR PUSTULOSIS (PPP) explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS (PPP) trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS (PPP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New biologic drug tested for debilitating skin blister disease
Disease control Recruiting nowThis study is observing a drug called Xeligekimab to see if it can help control moderate-to-severe palmoplantar pustulosis (PPP), a chronic skin disease that causes painful blisters and scales on the palms and soles. It will involve 10 adult patients who have not responded well t…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: PHASE4 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Apr 04, 2026 07:42 UTC
-
New pill trial offers hope for stubborn skin condition
Disease control Recruiting nowThis study is testing a new oral medication called ivarmacitinib for people with palmoplantar pustulosis, a painful skin condition causing blisters on hands and feet. Sixty adults who haven't benefited from standard treatments will take one pill daily for 12 weeks. Researchers wi…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Apr 04, 2026 07:35 UTC